Navigation Links
Instrumentation Laboratory Wins Patent Infringement and Unfair Competition Trial Against Diagnostica Stago Relating to Reagents for Hemostasis Diagnostics
Date:5/4/2009

- Court Orders Confiscation of Diagnostica Stago's Inventory of Infringing Products -

BEDFORD, Mass., May 4 /PRNewswire/ -- Instrumentation Laboratory Company and its parent company Instrumentation Laboratory S.p.A. (IL) today announced that the Paris First Level Civil Court determined that Diagnostica Stago infringed the French counterparts of two European patents licensed exclusively to IL, and committed acts of unfair competition due to denigrating advertisements. As a result, the Court ruled in part that: 1) Diagnostica Stago must cease manufacturing and selling its infringing products, STA-Staclot APC-R kits and STAGEN Kit FVM Mutation, and must cease denigrating advertisements concerning IL's products, 2) Diagnostica Stago's inventory of STA-Staclot APC-R kits and STAGEN Kit FVM Mutation may be confiscated for potential future destruction, and 3) Diagnostica Stago must pay IL the sum of 2,000,000 euros (approximately $2,600,000 US) as an advance on damages for the infringement and unfair competition, plus attorneys' fees. The court's decision may be appealed.

IL is the exclusive licensee of two patents, EP 0 608 235 and EP 0 690 991, covering inventions from the world-renowned researcher, Dr. Bjorn Dahlback, relating to the detection of thrombophilia, a coagulation disorder, in human blood. The first patent relates to a method for diagnosing a human blood coagulation disorder called resistance to APC (also known as activated protein C resistance), while the second patent additionally relates to a method for determining the presence of gene mutations of Factor V, which is one of the causes of thrombophilia.

"Litigation is not our first preference. However, our belief that Diagnostica Stago violated our patent rights and unfairly advertised by disparaging IL's product, forced us to pursue legal action. We are pleased with the Court's decision," said Josep Manent, Chief Executive at IL. "Our excellent HemosIL and Chromogenix reagent product line offers a broad spectrum of diagnostic tests, including assays for the detection of APC resistance and factor V Leiden mutations. We are committed to providing current and future customers around the world with these tests, to ensure that all hemostasis labs have access to the very best diagnostic tools for the highest quality patient care."

IL offers tests for identifying resistance to APC, a cause of thrombophilia. Today, IL offers a comprehensive line of HemosIL reagents for the diagnosis of thrombophilia, including antithrombin, protein C, protein S, activated protein C resistance, factor V Leiden, homocysteine, ThromboPath, and Xpert HemosIL FII & FV molecular. Additionally, HemosIL reagents are available for the management of antiphospholipid syndrome, coagulation factors, von Willebrand disease, fibrinolysis, and general screening and anticoagulant monitoring. Coupled with the ACL family of instruments, IL brings automation to the hemostasis lab. IL is dedicated to providing constant innovation through the highest quality, fully integrated solutions.

Instrumentation Laboratory (www.ilus.com) is a worldwide developer, manufacturer and distributor of in vitro diagnostic instruments, related reagents and controls for use primarily in hospitals and independent clinical laboratories. The company's product lines include critical care systems, hemostasis systems and information management systems. IL's GEM product offerings, part of the critical care line, include the GEM Premier(TM) 4000 analyzer with Intelligent Quality Management (iQM), the new GEM Premier 3500 analyzer with iQM and the GEM PCL Plus(TM), a portable coagulation analyzer. IL's hemostasis portfolio includes the ACL TOP family of hemostasis testing systems, fully automated, high-productivity analyzers, including the ACL TOP and the new ACL TOP 500 CTS. IL also offers the ACL ELITE and ELITE PRO(TM), other hemostasis analyzers and the HemosIL line of reagents.

The Instrumentation Laboratory logo, GEM, iQM, HemosIL, ACL, ACL TOP, ACL ELITE, ACL AcuStar, Premier and GEM OPL are trademarks of Instrumentation Laboratory Company and/or one of its subsidiaries or parent companies, and may be registered in the United States Patent and Trademark Office and in other jurisdictions. All other product names, company names, marks, logos, and symbols are trademarks of their respective owners.


'/>"/>
SOURCE Instrumentation Laboratory Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Instrumentation Laboratory Wins Extended Agreement With MedAssets Supply Chain Systems for Critical Care Portfolio
2. Instrumentation Laboratory Announces ILeader Panel of Experts as Part of 50th Anniversary Program
3. Frost & Sullivan Recognizes Waters Corporation for Its Pioneering, High Customer Value Analytical Instrumentation Product, SYNAPT HDMS
4. Instrumentation Laboratory Receives Performance Award from Premier for Second Consecutive Year
5. Instrumentation Laboratory Launches ACL Top(R) 500 CTS Hemostasis Testing System
6. Beckman Coulter to Acquire Flow Cytometry Instrumentation Business From Dako
7. Instrumentation Laboratory Named Top of Class by Respiratory Care Managers
8. PLUS Diagnostics Opens West Coast Laboratory to Support Increased Demand for Anatomic Pathology Services
9. Misonix Announces the Sale of Its Ultrasonic Laboratory Business for $3.5 Million to iSonix LLC
10. Global Med Technologies(R), Inc. Licenses Its Leading European Blood and Laboratory Solutions to Homburg, Germany Clinic Blood Center
11. Covance Central Laboratory Receives CAP Accreditation in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic ... many turn to unhealthy avenues, such as drug or alcohol abuse, as a coping ... released tools for healthy coping following a traumatic event. , Trauma sufferers tend to ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
(Date:6/24/2016)... CAMBRIDGE, Mass. , June 24, 2016 /PRNewswire/ ... the Spaulding Rehabilitation Network,s Dean Center for ... of Physical Medicine and Rehabilitation, MIT Hacking Medicine, ... Center for Innovation, today announced the five finalists ... Hackathon for Lyme disease.  More than 100 scientists, ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016  American Respiratory ... testing company, is now able to perform sophisticated lung assessments in ... Medical Technologies , Inc. Patients are no longer ... to ndd,s EasyOne PRO ® , ARL patients like Jeanne R. ... testing done in the comfort of her own home. ...
Breaking Medicine Technology: